ASPH is upregulated from pre-malignant pancreatic lesions (PanINs, MCN, and IPMN), substantially enhanced in MCAC, advanced/spontaneously metastatic pancreatic cancer, and extremely aggressive UC-OGC. This evidence concerns the gene ASPH and pancreatic intraductal papillary-mucinous neoplasm.